blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2647370

EP2647370 - INFUSION PREPARATION [Right-click to bookmark this link]
Former [2013/41]TRANSFUSION PREPARATION
[2019/08]
StatusNo opposition filed within time limit
Status updated on  03.01.2020
Database last updated on 24.04.2024
FormerThe patent has been granted
Status updated on  25.01.2019
FormerGrant of patent is intended
Status updated on  02.04.2018
FormerExamination is in progress
Status updated on  23.01.2017
Most recent event   Tooltip01.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 03.08.2022  [2022/31]
Applicant(s)For all designated states
Otsuka Pharmaceutical Factory, Inc.
115, Aza Kuguhara
Tateiwa
Muya-cho
Naruto-shi
Tokushima 7728601 / JP
[2018/38]
Former [2013/41]For all designated states
Otsuka Pharmaceutical Factory, Inc.
115 Aza-Kuguhara Tateiwa Muya-cho Naruto-shi
Tokushima 772-8601 / JP
Inventor(s)01 / TANI, Seiji
c/o OTSUKA PHARMACEUTICAL FACTORY INC.
115,Aza Kuguhara
Tateiwa
Muya-cho
Naruto-shi, Tokushima 7728601 / JP
02 / MITSUMOTO, Yasuhiro
c/o OTSUKA PHARMACEUTICAL FACTORY INC.
115, Aza Kuguhara
Tateiwa
Muya-cho
Naruto-shi, Tokushima 7728601 / JP
 [2018/38]
Former [2013/41]01 / TANI, Seiji
c/o OTSUKA PHARMACEUTICAL FACTORY INC.
115 Aza Kuguhara
Tateiwa
Muya-cho
Naruto-shi Tokushima 772-8601 / JP
02 / MITSUMOTO, Yasuhiro
c/o OTSUKA PHARMACEUTICAL FACTORY INC.
115 Aza Kuguhara
Tateiwa
Muya-cho
Naruto-shi Tokushima 772-8601 / JP
Representative(s)Hoffmann Eitle
Patent- und Rechtsanwälte PartmbB
Arabellastraße 30
81925 München / DE
[2019/09]
Former [2013/41]HOFFMANN EITLE
Patent- und Rechtsanwälte
Arabellastrasse 4
81925 München / DE
Application number, filing date11845978.328.11.2011
[2019/09]
WO2011JP77392
Priority number, dateJP2010026561129.11.2010         Original published format: JP 2010265611
[2013/41]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012073891
Date:07.06.2012
Language:JA
[2012/23]
Type: A1 Application with search report 
No.:EP2647370
Date:09.10.2013
Language:EN
[2013/41]
Type: B1 Patent specification 
No.:EP2647370
Date:27.02.2019
Language:EN
[2019/09]
Search report(s)International search report - published on:JP07.06.2012
(Supplementary) European search report - dispatched on:EP02.05.2014
ClassificationIPC:A61K9/08, A61K9/107, A61K31/07, A61K31/122, A61K31/198, A61K31/215, A61K31/355, A61K31/375, A61K31/4415, A61K31/519, A61K31/593, A61K31/7004, A61K31/702, A61K31/714, A61P7/08, A61K9/00
[2014/22]
CPC:
A61K9/0029 (EP,US); A61K9/08 (KR); A61M5/1407 (US);
A23L33/115 (US); A23L33/125 (US); A23L33/15 (US);
A23L33/175 (US); A61J1/2093 (US); A61K31/07 (EP,KR,US);
A61K31/122 (EP,KR,US); A61K31/198 (EP,KR,US); A61K31/215 (KR);
A61K31/355 (EP,KR,US); A61K31/375 (EP,US); A61K31/4172 (EP,US);
A61K31/4415 (EP,US); A61K31/51 (EP,US); A61K31/519 (EP,US);
A61K31/525 (EP,US); A61K31/593 (EP,US); A61K31/675 (EP,US);
A61K31/685 (EP,US); A61K31/7004 (EP,US); A61K31/714 (EP,US);
A61K33/14 (EP,US); A61K36/48 (US); A61K45/06 (EP,US);
A61K9/107 (KR); A61P3/02 (EP); A61P7/08 (EP);
A23V2002/00 (US) (-)
C-Set:
A61K31/07, A61K2300/00 (US,EP);
A61K31/122, A61K2300/00 (EP,US);
A61K31/355, A61K2300/00 (EP,US);
A61K31/375, A61K2300/00 (EP,US);
A61K31/4415, A61K2300/00 (US,EP);
A61K31/51, A61K2300/00 (US,EP);
A61K31/525, A61K2300/00 (EP,US);
A61K31/593, A61K2300/00 (EP,US);
A61K31/714, A61K2300/00 (US,EP);
A61K33/14, A61K2300/00 (US,EP)
(-)
Former IPC [2013/41]A61K9/08, A61K9/107, A61K31/07, A61K31/122, A61K31/198, A61K31/215, A61K31/355, A61K31/375, A61K31/4415, A61K31/519, A61K31/593, A61K31/7004, A61K31/702, A61K31/714, A61P7/08
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2013/41]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:INFUSIONSPRÄPARAT[2019/08]
English:INFUSION PREPARATION[2019/08]
French:PRÉPARATION POUR INFUSION[2019/08]
Former [2013/41]TRANSFUSIONSPRÄPARAT
Former [2013/41]TRANSFUSION PREPARATION
Former [2013/41]PRÉPARATION POUR TRANSFUSION
Entry into regional phase13.06.2013Translation filed 
13.06.2013National basic fee paid 
13.06.2013Search fee paid 
13.06.2013Designation fee(s) paid 
13.06.2013Examination fee paid 
Examination procedure13.06.2013Examination requested  [2013/41]
28.11.2014Amendment by applicant (claims and/or description)
14.09.2016Despatch of a communication from the examining division (Time limit: M06)
23.03.2017Reply to a communication from the examining division
03.04.2018Communication of intention to grant the patent
13.08.2018Fee for grant paid
13.08.2018Fee for publishing/printing paid
13.08.2018Receipt of the translation of the claim(s)
Divisional application(s)EP17164509.6  / EP3210598
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.09.2016
Opposition(s)28.11.2019No opposition filed within time limit [2020/06]
Fees paidRenewal fee
16.11.2013Renewal fee patent year 03
25.11.2014Renewal fee patent year 04
18.11.2015Renewal fee patent year 05
24.11.2016Renewal fee patent year 06
23.11.2017Renewal fee patent year 07
26.11.2018Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU28.11.2011
AL27.02.2019
AT27.02.2019
CY27.02.2019
CZ27.02.2019
DK27.02.2019
EE27.02.2019
ES27.02.2019
FI27.02.2019
HR27.02.2019
IT27.02.2019
LT27.02.2019
LV27.02.2019
MC27.02.2019
MK27.02.2019
MT27.02.2019
NL27.02.2019
PL27.02.2019
RO27.02.2019
RS27.02.2019
SE27.02.2019
SI27.02.2019
SK27.02.2019
SM27.02.2019
TR27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
IS27.06.2019
PT27.06.2019
[2022/31]
Former [2021/34]HU28.11.2011
AL27.02.2019
AT27.02.2019
CY27.02.2019
CZ27.02.2019
DK27.02.2019
EE27.02.2019
ES27.02.2019
FI27.02.2019
HR27.02.2019
IT27.02.2019
LT27.02.2019
LV27.02.2019
MC27.02.2019
MT27.02.2019
NL27.02.2019
PL27.02.2019
RO27.02.2019
RS27.02.2019
SE27.02.2019
SI27.02.2019
SK27.02.2019
SM27.02.2019
TR27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
IS27.06.2019
PT27.06.2019
Former [2021/33]HU28.11.2011
AL27.02.2019
AT27.02.2019
CY27.02.2019
CZ27.02.2019
DK27.02.2019
EE27.02.2019
ES27.02.2019
FI27.02.2019
HR27.02.2019
IT27.02.2019
LT27.02.2019
LV27.02.2019
MC27.02.2019
NL27.02.2019
PL27.02.2019
RO27.02.2019
RS27.02.2019
SE27.02.2019
SI27.02.2019
SK27.02.2019
SM27.02.2019
TR27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
IS27.06.2019
PT27.06.2019
Former [2021/26]AL27.02.2019
AT27.02.2019
CY27.02.2019
CZ27.02.2019
DK27.02.2019
EE27.02.2019
ES27.02.2019
FI27.02.2019
HR27.02.2019
IT27.02.2019
LT27.02.2019
LV27.02.2019
MC27.02.2019
NL27.02.2019
PL27.02.2019
RO27.02.2019
RS27.02.2019
SE27.02.2019
SI27.02.2019
SK27.02.2019
SM27.02.2019
TR27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
IS27.06.2019
PT27.06.2019
Former [2020/36]AL27.02.2019
AT27.02.2019
CZ27.02.2019
DK27.02.2019
EE27.02.2019
ES27.02.2019
FI27.02.2019
HR27.02.2019
IT27.02.2019
LT27.02.2019
LV27.02.2019
MC27.02.2019
NL27.02.2019
PL27.02.2019
RO27.02.2019
RS27.02.2019
SE27.02.2019
SI27.02.2019
SK27.02.2019
SM27.02.2019
TR27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
IS27.06.2019
PT27.06.2019
Former [2020/17]AL27.02.2019
AT27.02.2019
CZ27.02.2019
DK27.02.2019
EE27.02.2019
ES27.02.2019
FI27.02.2019
HR27.02.2019
IT27.02.2019
LT27.02.2019
LV27.02.2019
NL27.02.2019
PL27.02.2019
RO27.02.2019
RS27.02.2019
SE27.02.2019
SI27.02.2019
SK27.02.2019
SM27.02.2019
TR27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
IS27.06.2019
PT27.06.2019
Former [2020/13]AL27.02.2019
AT27.02.2019
CZ27.02.2019
DK27.02.2019
EE27.02.2019
ES27.02.2019
FI27.02.2019
HR27.02.2019
IT27.02.2019
LT27.02.2019
LV27.02.2019
NL27.02.2019
PL27.02.2019
RO27.02.2019
RS27.02.2019
SE27.02.2019
SI27.02.2019
SK27.02.2019
SM27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
IS27.06.2019
PT27.06.2019
Former [2020/03]AL27.02.2019
AT27.02.2019
CZ27.02.2019
DK27.02.2019
EE27.02.2019
ES27.02.2019
FI27.02.2019
HR27.02.2019
IT27.02.2019
LT27.02.2019
LV27.02.2019
NL27.02.2019
PL27.02.2019
RO27.02.2019
RS27.02.2019
SE27.02.2019
SK27.02.2019
SM27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
IS27.06.2019
PT27.06.2019
Former [2019/52]AL27.02.2019
CZ27.02.2019
DK27.02.2019
EE27.02.2019
ES27.02.2019
FI27.02.2019
HR27.02.2019
IT27.02.2019
LT27.02.2019
LV27.02.2019
NL27.02.2019
PL27.02.2019
RO27.02.2019
RS27.02.2019
SE27.02.2019
SK27.02.2019
SM27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
IS27.06.2019
PT27.06.2019
Former [2019/49]AL27.02.2019
CZ27.02.2019
DK27.02.2019
EE27.02.2019
ES27.02.2019
FI27.02.2019
HR27.02.2019
IT27.02.2019
LT27.02.2019
LV27.02.2019
NL27.02.2019
RO27.02.2019
RS27.02.2019
SE27.02.2019
SK27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
IS27.06.2019
PT27.06.2019
Former [2019/48]DK27.02.2019
ES27.02.2019
FI27.02.2019
HR27.02.2019
IT27.02.2019
LT27.02.2019
LV27.02.2019
NL27.02.2019
RS27.02.2019
SE27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
IS27.06.2019
PT27.06.2019
Former [2019/47]ES27.02.2019
FI27.02.2019
HR27.02.2019
IT27.02.2019
LT27.02.2019
LV27.02.2019
NL27.02.2019
RS27.02.2019
SE27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
IS27.06.2019
PT27.06.2019
Former [2019/46]FI27.02.2019
HR27.02.2019
IT27.02.2019
LT27.02.2019
LV27.02.2019
NL27.02.2019
RS27.02.2019
SE27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
IS27.06.2019
PT27.06.2019
Former [2019/39]FI27.02.2019
HR27.02.2019
LT27.02.2019
LV27.02.2019
NL27.02.2019
RS27.02.2019
SE27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
IS27.06.2019
PT27.06.2019
Former [2019/38]FI27.02.2019
LT27.02.2019
NL27.02.2019
SE27.02.2019
BG27.05.2019
NO27.05.2019
GR28.05.2019
PT27.06.2019
Former [2019/37]FI27.02.2019
LT27.02.2019
NL27.02.2019
SE27.02.2019
NO27.05.2019
GR28.05.2019
PT27.06.2019
Former [2019/34]FI27.02.2019
LT27.02.2019
NL27.02.2019
SE27.02.2019
NO27.05.2019
PT27.06.2019
Former [2019/33]FI27.02.2019
LT27.02.2019
NO27.05.2019
PT27.06.2019
Documents cited:Search[Y]JP2005330244  ;
 [XY]EP0747033  (GREEN CROSS CORP [JP]) [X] 1 * the whole document * * example 1 * * page 13; table 5 * [Y] 1-5;
 [XY]US5728681  (KIDO TAKAE [JP], et al) [X] 1 * figures 1-3,5-7; example 1 * * the whole document * [Y] 1-5;
 [Y]EP1632233  (OTSUKA PHARMA CO LTD [JP]) [Y] 1-5 * the whole document * * claims 1,4 * * paragraphs [0001] , [0008] - [0010] - [0034] *;
 [Y]  - DATABASE WPI, 0, Derwent World Patents Index, vol. 2006, no. 01, Database accession no. 2006-003842, XP002723447 & JP2005330244 A 20051202 (AJINOMOTO KK) [Y] 1-5 * the whole document *
International search[Y]JPH06209979  (GREEN CROSS CORP);
 [Y]JPH08709  (GREEN CROSS CORP);
 [Y]JP2000143509  (NISSHO KK);
 [Y]JP2001328934  (NIPRO CORP);
 [Y]JP2007137836  (AJINOMOTO KK)
by applicantJPS6320550B
 JPS63309263
 JPH024671
 JPH055138U
 JP2003095937
 JP2004189677
    - JAPANESE PHARMACOLOGY & THERAPEUTICS, (1996), vol. 24, no. 10, page 2151
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.